You are here
Coronavirus (COVID-19): Information on medicines and medical devices
The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.
Please read the information below before contacting the TGA to see if your question is already answered.
Filters
Topics and product types
Audience
- Remove Advertisers filter Advertisers (1)
- Remove Consumers filter Consumers (11)
- Health professionals (14) Apply Health professionals filter
- Remove Manufacturers filter Manufacturers (5)
- Sponsors (7) Apply Sponsors filter
Filters applied:
- (-) Remove Consumers filter Consumers
- (-) Remove Advertisers filter Advertisers
- (-) Remove Manufacturers filter Manufacturers
24 August 2021
Where suitable, TGA inspectors will undertake remote and/or hybrid Good Manufacturing Practice (GMP) domestic inspections during the COVID-19 pandemic.
26 August 2020
Dental board practitioners who are registered specialists in oral medicine have now been added to the list of specialist health practitioners who are permitted to initiate treatment using hydroxychloroquine
3 August 2020
Information on advertising of products related to COVID-19, GMP information for sponsors and manufacturers and access to coronavirus tests, medicines and vaccines, including medicine shortages
1 July 2020
Pharmacies can return children's paracetamol liquid formulations to front-of-counter, but the one unit limit on sales remains in place.
8 May 2020
Consumers should be alert to misleading claims made online about Miracle Mineral Solution (MMS). The TGA has not approved MMS for use to treat, cure, prevent or alleviate any disease or condition.
6 May 2020
Information on an exemption for radiopharmaceuticals that facilitates interstate supply during COVID-19.
28 April 2020
Advice for faecal microbiota transplant (FMT) providers on safety protections related to COVID-19.
2 April 2020
Information about the steps we are taking to make sure there are enough ventilators to match demand during the COVID-19 pandemic
27 March 2020
We have investigated a report that intravenous high-dose vitamin C may be beneficial in the management of COVID-19
24 March 2020
Only certain types of specialists will now be able to prescribe hydroxychloroquine to new patients
Pages
Further information
Contact TGA Info
Tel: 1800 020 653
Email: info@tga.gov.au
Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.
Department of Health
Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.
Follow us
